» Articles » PMID: 16860926

The Clearance of BNP Modeled Using the NT-proBNP-BNP Relationship

Overview
Journal Biosystems
Specialty Biology
Date 2006 Jul 25
PMID 16860926
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The ventricular myocardium simultaneously secretes two natriuretic peptides useful in the evaluation of heart failure: BNP, hormonally active, and NT-proBNP, the N-terminal end, non-hormonally active, but ultimately their concentrations differ and their clearance patterns are poorly defined.

Methods: We measured NT-proBNP and BNP in patients with and without heart failure and compared their concentrations using regression analysis.

Results: The relationship between NT-proBNP with BNP is nonlinear. Between 45 and 70 pmol of BNP/L (class II heart failure) the slope is much higher than in other ranges and the NT-proBNP/BNP ratio reaches its maximum in patients with class II NYHA heart failure.

Conclusions: The difference in concentration for NT-proBNP and BNP can be related to the diffusion across the renal basement membrane. Their ratio is nonlinear because BNP is cleared faster than in patients with class II heart failure than other classes or normal, suggesting a change in a non-renal mode of clearance.

Citing Articles

NT-proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme.

Sweeney C, Pharithi R, Kerr B, Ryan C, Ryan F, Collins L ESC Heart Fail. 2021; 8(6):5081-5091.

PMID: 34586748 PMC: 8712901. DOI: 10.1002/ehf2.13576.


Urinary NT-proBNP levels and echocardiographic parameters for patent ductus arteriosus.

Khan S, Sithisarn T, Bada H, Vranicar M, Westgate P, Hanna M J Perinatol. 2017; 37(12):1319-1324.

PMID: 28906496 DOI: 10.1038/jp.2017.139.


A review on B-type natriuretic peptide monitoring: assays and biosensors.

Maalouf R, Bailey S Heart Fail Rev. 2016; 21(5):567-78.

PMID: 26979601 PMC: 4983280. DOI: 10.1007/s10741-016-9544-9.


Elevated Levels of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Chronic Dyspnea and Moderate Renal Dysfunction: Decreased Clearance or Increased Cardiac Stress.

Wieshammer S, Dreyhaupt J, Basler B Cardiorenal Med. 2012; 1(3):156-163.

PMID: 22258538 PMC: 3142100. DOI: 10.1159/000329537.


Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.

Chiong J, Jao G, Adams Jr K Heart Fail Rev. 2009; 15(4):275-91.

PMID: 19360469 DOI: 10.1007/s10741-009-9141-2.